Physician
Radiology
Dr. Michael Hagan, MD
|
|
Give Review
Dr. Michael Hagan practices Radiology. He researched medicine at Baylor College of Medicine. Michael Hagan, MD is also a published doctor. He has 63 publication published. The most recent publication is: Association between coronary heart disease and cancers of the breast, prostate, and colon.
Publications
- Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of radiation therapy...
- Novel neoadjuvant therapy paradigms for bladder cancer: Results from the National Cancer Center Institute Forum.
- Availability of Single-Fraction Palliative Radiotherapy for Cancer Patients Receiving End-of-Life Care within the Veterans Healthcare Administration.
- Examining the relationship between pre- and postimplant geometry in prostate LDR brachytherapy and its correlation with dosimetric quality using the similarity concept.
- Identifying Appropriate Patients for Early Salvage Radiotherapy after Prostatectomy.
- Elective irradiation of pelvic lymph nodes during postprostatectomy salvage radiotherapy.
- WE-A-BRB-07: Critical Analysis of Strength-Based Medical Event Definition in Prostate Seed Brachytherapy Based on a Comparative Retrospective Pre- and Post-Implant Ana...
- Phase I/II trial of single-fraction high-dose-rate brachytherapy-boosted hypofractionated intensity-modulated radiation therapy for localized adenocarcinoma of the pro...
- Factors Associated with Program Utilization of Radiation Therapy Treatment for VHA and Medicare Dually Enrolled Patients.
- Regulatory evaluation of prostate volume implants: Pitfalls of a retrospective assessment.
- Evaluation of a cognitive intervention program for juvenile offenders.
- Five-year accuracy of assessments of high risk for sexual recidivism of adolescents.
- Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06.
- Lapatinib resistance in HCT116 cells is mediated by elevated MCL-1 expression and decreased BAK activation and not by ERBB receptor kinase mutation.
- Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via sup...
- OSU-03012 stimulates PKR-like endoplasmic reticulum-dependent increases in 70-kDa heat shock protein expression, attenuating its lethal actions in transformed cells.
- Human chorionic gonadotropin (hCG) interacts with lovastatin and ionizing radiation to modulate prostate cancer cell viability in vivo.
- Transient exposure of carcinoma cells to RAS/MEK inhibitors and UCN-01 causes cell death in vitro and in vivo.
- Low-dose BBR3610 toxicity in colon cancer cells is p53-independent and enhanced by inhibition of epidermal growth factor receptor (ERBB1)-phosphatidyl inositol 3 kinas...
- Radiation-induced PARP activation is enhanced through EGFR-ERK signaling.
- Survival benefit for early hormone ablation in biochemically recurrent prostate cancer.
- Radiation-induced cell signaling: inside-out and outside-in.
- Human chorionic gonadotropin modulates prostate cancer cell survival after irradiation or HMG CoA reductase inhibitor treatment.
- MEK1/2 inhibition promotes Taxotere lethality in mammary tumors in vivo.
- Screening for suicide among juvenile delinquents: reliability and validity evidence for the Suicide Screening Inventory (SSI).
- Radiation-stimulated ERK1/2 and JNK1/2 signaling can promote cell cycle progression in human colon cancer cells.
- H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent.
- Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival.
- RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adju...
- Epidermal growth factor and ionizing radiation up-regulate the DNA repair genes XRCC1 and ERCC1 in DU145 and LNCaP prostate carcinoma through MAPK signaling.
- Stress and radiation-induced activation of multiple intracellular signaling pathways.
- Inhibitors of MEK1/2 interact with UCN-01 to induce apoptosis and reduce colony formation in mammary and prostate carcinoma cells.
- Pharmocologic inhibitors of the mitogen activated protein kinase cascade have the potential to interact with ionizing radiation exposure to induce cell death in carcin...
- Perception of preventive health needs in a prostate-cancer screening population: a preliminary report.
- Burden of premenstrual dysphoric disorder on health-related quality of life.
- Altered pharmacokinetic and tumour localization properties of Fab'' fragments of a murine monoclonal anti-CEA antibody by covalent modification with low molecular weig...
- Erythroid progenitor (BFU-E, CFU-E) proliferation as inferred from 5'bromodeoxyuridine labeling.
- Development and validation of the Premenstrual Symptoms Impact Survey (PMSIS): a disease-specific quality of life assessment tool.
- Association between coronary heart disease and cancers of the breast, prostate, and colon.
- Impaired repair of UVC-induced DNA damage in L5178Y-R cells: sedimentation studies with the use of 5''-bromodeoxyuridine photolysis.
- Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes.
- Cell kinetics of GM-CFC in the steady state.
- Effects of heavy ions on cycling stem cells.
- Superior sulcus lung tumors: impact of local control on survival.
- Effect of radiation on the regulation of sodium-dependent glucose transport in LLC-PK1 epithelial cell line: possible model for gene expression.
- Caffeine-induced apoptosis reveals a persistent lesion after treatment with bromodeoxyuridine and ultraviolet-B light.
- Changes in tumor proliferation of rectal cancer induced by preoperative 5-fluorouracil and irradiation.
- Autocrine loops with positive feedback enable context-dependent cell signaling.
- Evaluation of clinical margins via simulation of patient setup errors in prostate IMRT treatment plans.
- Tumor proliferation in rectal cancer following preoperative irradiation.
- A dynamic compensation strategy to correct patient-positioning errors in conformal prostate radiotherapy.
- A strategy to correct for intrafraction target translation in conformal prostate radiotherapy: simulation results.
- A comparison of HDR brachytherapy and IMRT techniques for dose escalation in prostate cancer: a radiobiological modeling study.
- MAPK dependence of DNA damage repair: ionizing radiation and the induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human prostate carcinoma cell...
- Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways.
- Ionizing radiation causes a dose-dependent release of transforming growth factor alpha in vitro from irradiated xenografts and during palliative treatment of hormone-r...
- Comparison of adjuvant versus salvage radiotherapy policies for postprostatectomy radiotherapy.
- Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with mu...
- Ionizing radiation-induced mitogen-activated protein (MAP) kinase activation in DU145 prostate carcinoma cells: MAP kinase inhibition enhances radiation-induced cell k...
- MAPK pathways in radiation responses.
- Radiotherapy-induced signal transduction.
- Monte Carlo dose verification of prostate patients treated with simultaneous integrated boost intensity modulated radiation therapy.
Schools
Baylor College Of Medicine
Baylor Assoc Hospital
Massachusetts General Hospital
Doctors Specialties
- Radiation Oncology
- Radiology
Accepted Insurances
Education
-
Massachusetts General Hospital -
Baylor College of Medicine
Drug Facts
| NPI NUMBER | 1861467003 | |
| NPPES Provider LastName | HAGAN | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 232980510 | |
| NPPES Provider State | VA | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 14.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861467003 |
| Last Name Of The Provider | HAGAN |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Douglas W. Arthur, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher R. Johnson, MD |
|
Dr. Sharon Outten, MD
This Doctor is OpenDoctor Recommended.
|